Roche got a big boost on Friday when a clinical trial testing its new blood cancer drug Gazyva proved successful. » Read More
European stocks eked out gains on Friday amid a decline in oil prices.
Novartis is discussing options with banks for selling its $13.8 billion stake in rival Roche, though a sale is not imminent.
European markets finished in the red on Thursday, as a slump in health care stocks weighed on investors, despite a recovery in oil.
The U.S. Food and Drug Administration recommended that blood should no longer be collected from regions where the Zika virus is circulating.
European equities closed sharply lower on Thursday, as a raft of weak earnings offset positive sentiment surrounding the rebound in oil prices.
The drug, alectinib, to be sold under the brand name Alecensa, was approved to treat patients with advanced ALK-positive non-small cell lung cancer whose disease has worsened after, or who could not tolerate, treatment with Pfizer's Xalkori. "Today's approval provides a new therapy for a group of patients who would have few treatment options once their disease...
NEW YORK, Dec 2- A U.S. appeals court refused on Wednesday to reconsider its decision invalidating a Sequenom Inc prenatal DNA test patent, a decision that could put in doubt the validity of a wide range of medical and biotechnology patents. Sequenom shares fell 9.5 percent to $1.62 on Wednesday. Sequenom's patent relates to the discovery of a way to detect fetal...
Goldman's Robert Boroujerdi presented seven future theme predictions and their investment implications in a note to clients Wednesday.
European equities closed the session mixed Wednesday as investors digested inflation numbers and contemplated the possibility of further stimulus.
European equities closed sharply lower on Friday as slumping commodity prices and weak earnings reports weighed on investor sentiment.
Norway's sovereign wealth fund, the largest in the world by assets, reported a loss in the third quarter of this year as the global sell-off in risk assets hit the fund's equity holdings.
European markets jumped higher on Thursday, after the European Central Bank's president said that policy would be re-examined in December.
Drugmaker Roche said its experimental medicine for multiple sclerosis performed better in a late-stage clinical trial than a commonly used therapy.
DAX all folks
European stocks ended lower on Thursday, after a flurry of corporate earnings came out from across the region.
Valuation are "very high" in the pharmaceutical sector, Roche CEO Severin Schwan told CNBC on Thursday after the company posted a rise in sales.
Avalanche Biotechnologies fell 56 percent, but CEO Thomas Chalberg declined to say whether he would buy more shares.
European equities closed mixed on Monday as investors reacted to new economic data and cheered updates from the pharmaceutical sector.
The stock-moving news flow started early out of the American Society of Clinical Oncology meeting in Chicago.
It's that time again. With researchers set to convene at the American Society of Clinical Oncology meeting, here are the stocks to watch.